Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00929539 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

A Phase 2 study of Type II Diabetes Mellitus, sponsored by Akros Pharma.

Completed
Registry status
Phase 2
Development phase
496
Enrollment target
20
Study locations

NCT00929539 is a Phase 2 study of Type II Diabetes Mellitus that has completed, run by Akros Pharma. The registered enrollment target is 496 participants, above the 103-participant average among 7 other Type II Diabetes Mellitus trials with a reported enrollment target (382% higher). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00929539, a Phase 2 study of Type II Diabetes Mellitus, has completed, sponsored by Akros Pharma.

COMPLETED
Registry status
Phase 2
Development phase
496 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the effect of JTT-130 on diabetes as well as the safety and tolerability of JTT-130 in obese Type 2 diabetic patients.

Conditions Studied

Type II Diabetes Mellitus

Interventions

  • DRUG JTT-130
  • DRUG JTT-130 Placebo

Study Locations (20)

California

  • - Encino
  • - Los Angeles
  • - Sacramento
  • - Spring Valley
  • - Valley Village
  • - Walnut Creek

Florida

  • - Delray Beach
  • - Hialeah
  • - Miami
  • - New Port Richey
  • - Ocala

Alabama

  • - Birmingham
  • - Muscle Shoals
  • - Scottsboro

Arizona

  • - Tucson

Connecticut

  • - Waterbury

Georgia

  • - Sandy Springs

Illinois

  • - Chicago

Indiana

  • - Indianapolis

Trial Details

FieldValue
Enrollment Target 496 participants
Start Date 2009-06
Est. Completion 2010-07
Phase Phase 2

Sponsor

Akros Pharma

18 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00929539

The ClinicalTrials.gov registry entry for NCT00929539 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 496 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 103-participant average among 7 other Type II Diabetes Mellitus trials with a reported enrollment target (382% higher). The listed sponsor is Akros Pharma, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type II Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which JTT-130 is the first listed.

NCT00929539 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Alabama.

Frequently Asked Questions

What is clinical trial NCT00929539 about?

NCT00929539 is a clinical study titled "Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients". The purpose of this study is to evaluate the effect of JTT-130 on diabetes as well as the safety and tolerability of JTT-130 in obese Type 2 diabetic patients.

What is the current status of trial NCT00929539?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 496 participants. The study started on 2009-06. Estimated completion is 2010-07.

What conditions does trial NCT00929539 study?

This clinical trial studies the following conditions: Type II Diabetes Mellitus.

What interventions are being tested in trial NCT00929539?

The interventions under investigation include: JTT-130 (DRUG), JTT-130 Placebo (DRUG).

Who is sponsoring clinical trial NCT00929539?

This trial is sponsored by Akros Pharma, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00929539 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type II Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type II Diabetes Mellitus

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.